Isuprel (Hospira, Inc.)


Welcome to the PulseAid listing for the Isuprel drug offered from Hospira, Inc.. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: ISOPROTERENOL HYDROCHLORIDE
SUBSTANCE NAME: ISOPROTERENOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
ROUTE: INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-03-21
END MARKETING DATE: 0000-00-00


Isuprel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIsuprel from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(mg/mL)
START MARKETING DATE: 2013-03-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1442_ccb8f8a1-d89f-46d9-a5d1-0e8bafca27fb
PRODUCT NDC: 0409-1442
APPLICATION NUMBER: NDA010515

Other ISOPROTERENOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthIsuprel
Hospira, Inc.Isuprel
Nexus Pharmaceuticals IncIsoproterenol Hydrochloride
Valeant Pharmaceuticals North America LLCIsuprel